Puma Biotechnology | Crediti Commerciali



Trade Debtors Cambiamento Data
Agios Pharmaceuticals USD 3.34M 765K 2025-03
Alnylam Pharmaceuticals USD 418.04M 12.73M 2025-03
Amgen USD 8.13B 1.35B 2025-03
Biogen USD 2B 127.7M 2025-03
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Daiichi Sankyo JPY 619.1B 5.07B 2025-03
Exelixis USD 281.64M 16.2M 2025-04
Gilead Sciences USD 4.39B 32M 2025-03
Glaxosmithkline GBP 7.32B 542M 2024-12
Incyte USD 823.13M 30.02M 2025-03
MacroGenics USD 4.31M 4.44M 2024-12
Moderna USD 306M 286M 2025-03
Novartis USD 9B 854M 2024-12
Pfizer USD 14.74B 32M 2025-03
PTC Therapeutics USD 210.5M 51.94M 2025-03
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sarepta Therapeutics USD 724.52M 74.8M 2025-03
Takeda JPY 725.25B 9.81B 2025-03
TG Therapeutics USD 129.18M 13.46M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Puma Biotechnology Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.